Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endologix Inc. ELGXQ

Healthcare
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the... see more

Recent & Breaking News (OTCPK:ELGXQ)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Endologix, Inc. (ELGX) on Behalf of Shareholders

Business Wire July 21, 2017

Endologix, Inc. to Announce Second Quarter 2017 Financial Results on August 2, 2017

Business Wire July 12, 2017

Endologix, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference

Business Wire July 10, 2017

Lifshitz & Miller LLP Announces Investigation of Aaron's, Inc., Axiom Holdings, Inc., Booz Allen Hamilton Holding Corporation, CenturyLink, Inc., Endologix, Inc., Sky Solar Holdings, Ltd. and Rightside Group, Ltd.

PR Newswire July 3, 2017

Medical Supplies Stocks on Investors' Radar -- Endologix, Microbot Medical, ConforMIS, and Insulet

PR Newswire June 21, 2017

ENDOLOGIX ALERT: J&W Investigates Endologix, Inc.; Long Term Investors Encouraged to Contact the Firm

PR Newswire June 13, 2017

Robbins Arroyo LLP: Endologix, Inc. (ELGX) Misled Shareholders According to a Recently Filed Class Action

Business Wire June 12, 2017

Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial

Business Wire June 3, 2017

Endologix Reports Positive Clinical Data from the Ovation LUCY Study

Business Wire May 31, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of First American Financial Corporation

Business Wire May 26, 2017

FDA Approval For Endologix's Nellix Likely Pushed To At Least 2020

Benzinga.com  May 18, 2017

Analyst On Endologix: No Sense In Downgrading Now

Benzinga.com  May 18, 2017

Endologix Provides an Update on the Nellix® Endovascular Aneurysm Sealing System U.S. Regulatory Status

Business Wire May 17, 2017

Research Reports Initiation on Healthcare Stocks -- Endologix, C. R. Bard, Insulet, and Vericel

PR Newswire May 12, 2017

Endologix Reports First Quarter 2017 Financial Results

Business Wire May 4, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. - ELGX

PR Newswire May 1, 2017

Endologix, Inc. to Host an Investor Conference Call to Discuss its Nellix® Endovascular Aneurysm Sealing System Presentation at the Society of Vascular Surgery Annual Meeting on June 3, 2017

Business Wire April 24, 2017

Endologix, Inc. to Announce First Quarter 2017 Financial Results on May 4, 2017

Business Wire April 17, 2017

Endologix Enters into $170 Million Credit Facility with Deerfield Management

Business Wire April 4, 2017

Endologix, Inc. Announces Enrollment of First Patients in ELEVATE IDE Clinical Study

Business Wire March 31, 2017